will go the questions. our the I’ll into Good Michaella. describe appreciate to fronts, QX right operational, step being the answering your the on This today’s afternoon, deeper look competitive full we’re and as it was provide an company. Ajay financial meaningful would and On we another share second with with progress forward us. call, with begin direction. you, highlights. I’ll QX the update in highlights, everyone. making landscape. commercial, quarter financials solid you begin clinical and on financial Thank with innovation We I
are sales institutions, while The hospitals academic of business quarter. pipeline the and and through We progressing engine, spanned the commercial centers. closing orders seven operational our resulted as and growing historical community building improvements free is out our concurrently commitments, in anticipated, this orders standing
clinical of and propositions responding all favorably. customers are We are value strategic our and economic, types sharing
approximately included in Our $XXX installations were no backlog $XX.X grew to orders million three million was quarter which upgrade. Revenue one and and there the removed.
now Our clarity costs. such, in We associated gross completed and three the negative. on margin have upgrades have Linac as quarter to Cobalt was
We XXXX have remaining and upgrades the a taking of are all million charge and six commitments. in more $X encompasses of XXXX that
We our despite negative are for move standing and company approach with this as the to forward. associated customers our right behind believe these we commitments them, the for is margin historical
burn rate This what amount we quarters Our the to cash expect was used ahead. reduce the capital quarter. million working in anticipated $XX burn we approximately in the was and of
given approximately our positioned and revenue of are well with year. cash cash the $XXX our reaffirming balance for million are we We guidance previously current and
the on to front. update commercial an turn Let’s
our process. up enhanced Our proportion Similarly, larger to sales footprint productivity. grown building U.S. are direct list has in and and our team fully ramping both international team target out we is strategically in our account place and
their capital markets. distributors partnerships success respective We have recently with secured of Australia Canada. breakthrough technologies track They and in each a record key have in launching
and drive confident these on program. our installations. both we execute comprehensive MRIdian continue with relationships have to readiness We and Operationally, their sales progress to strong in are distributors ability on significant
were Over showcased are on across purchase service. were ASTRO of clinical while XXX MRIdian plan pancreas indications. a just were in on Motion, lymphomas, physics methodical from research variety quality delivering a abdominal representing the We presentations concurrently patients and Milan. clinical adrenal There ovarian and over Rec order clear successful dozen Organ cancers. tumors quality highlighting improvements outcomes assurance. returned conference cycles from customer to We two rectal A lung and clinical Rev impressive excellent conference. presentations and making takeaways peripheral metastasis, posters and breast, ligand There with patients few and reported liver, central and
in moving are types customers this it regions. SBRT, toward is global movement spans cancer First, pronounced and
MRIdian presentations were and Conference. Linacs is pervasive direction interest stage at and market moving The generally in Second, our MR center specifically is growing, MR in and the
MRIdian Third, fully the differentiated we to truly is. appreciate drive more out clearly uniquely are we from and how desired how competition. How trend suited stand SBRT the customers
and vital the precise and able healthy at dose. talking in the when solution. are the concurrently a tissues only and soft delivers contract others that what It and risk. are also While time therefore, future, organ selling in tumor target ablative strikes is and do that is to in about tissue. is the automatically shape clinically groundbreaking may they system real dose system stops an automatically be actively is It accurate a tumors preserves plan only MRIdian when a we
a opportunity about SBRT XX% patients versus utilizing now Linacs. XX% are worthy clinical in data. team they are expansive and with customers have XXX% armed We of top of commercial Our unconventional to the
patients, and his have times, treatment hard delivered approximately of and are Jersey about of physicians, abstracts, New subject XX on treated and a notice, to patient and X,XXX Patients X,XXX patient Hospital RV, treatments about cancer seek, have that We peer-reviewed providers to shorter exactly from excellent greater access table payers outcomes, posters, we care. publications, adaptive favorable hundreds the been drove superior taking recently area back the and lot parking patients, knowing in hospital home fraction. Think treatments what after economics, Ford at Greater centers hours Henry MRIidian, our and throughput team the learned to higher final York-New his be market. in in in of home. the innovation is us right home and the night his the our near treated This fifth drive his of his between slept between SBRT close He home working great cancer the separate to on and made MRIdian. system patients’ vehicle Detroit. his every further safely to will Future bring power is
the are pipeline accurate personalized uniquely positioned and over describe SBRT drive on and toward we groundbreaking. that we We freestanding extending market academic the get focused are will that we’ll that embedded elegant our is this responding are, precise, more always laser proposition. be to believe capabilities space and delivering leadership commercializing moving and that future and our faster, position Customers our sought, have what are customers medicine smarter favorably is value Customers to clinics to from In trend. time. summary, centers is
of of to turn building XX% and year, MRIdian centers strategic pipelines Ajay. we’re in the share in growing. accounts, traveling already the validating to economic about our Patients comprehensive Our ahead to foundation that, commercial, the cancer we in With innovation the is system. early or opportunity I’ll clinical call process NCI and that the MRIdian is and are on installed It of designated us. are over is value but capitalize about rising. are excited
